Treatment of Periodontitis With Er:YAG Laser
| Status: | Recruiting |
|---|---|
| Conditions: | Dental |
| Therapuetic Areas: | Dental / Maxillofacial Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/16/2018 |
| Start Date: | March 1, 2018 |
| End Date: | January 1, 2019 |
| Contact: | Philip Kang, DDS, MS |
| Email: | pyk2104@cumc.columbia.edu |
| Phone: | 201-982-4584 |
Treatment of Periodontitis Utilizing Two Different Modalities: Erbium-doped Yttrium Aluminium Garnet (Er:YAG) Laser and Conventional Mechanical Debridement
The purpose of the research project is to gain information on the best and most comfortable
way to treat the periodontal disease. The two options are scaling and root planning and laser
therapy, both of which been shown to be effective and regularly used in clinic. This study is
to examine the changes in clinical parameters for periodontal disease performed with these
two different treatment modalities.
way to treat the periodontal disease. The two options are scaling and root planning and laser
therapy, both of which been shown to be effective and regularly used in clinic. This study is
to examine the changes in clinical parameters for periodontal disease performed with these
two different treatment modalities.
Patients will be randomized to have either right of left side of the mouth (upper right and
lower right quadrants and upper left and lower left quadrants) treated with conventional
scaling and root planing, the other half will be treated according to the Morita Laser
scaling protocol. Clinical parameters will be recorded before therapy at baseline and at the
3 month visit, along with a periodontal maintenance.
lower right quadrants and upper left and lower left quadrants) treated with conventional
scaling and root planing, the other half will be treated according to the Morita Laser
scaling protocol. Clinical parameters will be recorded before therapy at baseline and at the
3 month visit, along with a periodontal maintenance.
Inclusion Criteria:
- Signed and dated Informed Consent
- Good general health
- Participants > 18 years of age
- Participants with > 20 teeth with 5 teeth, including at least 1 molar, in each
quadrant of the mouth
- Participants with > 30% of the present teeth with Probing depths of > 4mm and Bleeding
on Probing
- Non-smoker and former smokers (stopped smoking > 1 year)
- Participants that have not received any periodontal treatment in the past 3 months
Exclusion Criteria:
- Participants with uncontrolled systemic diseases that could affect the treatment
outcome such as Diabetes with HbA1c > 7.0 percent, rheumatoid arthritis,
immunosuppression, HIV with detectable viral loads
- Participants requiring antibiotic prophylaxis for any cardiovascular conditions or
after any transplant and/or replacement procedures
- Pregnant women
- Patients treated with systemic antibiotic therapy of periodontal/mechanical/local
delivery therapy within 6 weeks prior to study entry and throughout the study duration
- Patients being chronically (two weeks or more) treated with any NSAIDs, steroids or
any medications known to affect soft tissue condition (excluding treatment with
Acetylsalicylic acid < 100 mg/day)
- Presence of orthodontic appliances, or any removable appliances that impinges on the
tissues being assessed.
- Presence of soft or hard tissue tumors of the oral cavity
- The presence of any medical or psychiatric condition or any other condition that, in
the opinion of the Investigator, could affect the successful participation of the
patient in the study
We found this trial at
1
site
Click here to add this to my saved trials
